Hematologic counts and clinical correlates in 1201 newly diagnosed lung cancer patients

Monaldi Archives for Chest Disease

Volumn 59, Issue 3, 2003, Pages 193-198

  Ferrigno, Domenico ^a   Buccheri, G ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Hemoglobin; Leukocytes; Lung cancer; Neutrophils; Platelets; Prognosis

Indexed keywords

HEMOGLOBIN; PLASMA PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ANTHROPOMETRY; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METASTASIS; MULTIVARIATE ANALYSIS; NEUTROPHIL; OUTCOMES RESEARCH; PROGNOSIS; PROSPECTIVE STUDY; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTOSIS; WEIGHT REDUCTION; ADENOCARCINOMA; DISEASE COURSE; LUNG SQUAMOUS CELL CARCINOMA;

EID: 1642566649     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Buccheri G, Ferrigno D. Prognostic factors in lung cancer: tables and comments. Eur Respir J 1994; 7: 1350-64.
2. Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group Experience. Journal of Clinical Oncology 1991; 9: 1618-26.
3. Rawson NSB, Peto J. An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research. British Journal of Cancer 1990; 61: 597-604.
4. World Health Organization. International histological classification of tumours. Berlin: Springer-Verlag, 1991.
5. Mountain CF. Revisions in the International System for Staging Lung Cancer [see comments]. Chest 1997; 111: 1710-7.
6. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM. Evaluation of chemotherapeutic agents. New York: Columbia University Press, 1949: 199-205.
7. Buccheri G. Chemotherapy and survival in non-small cell lung cancer. The old 'vexata questio'. Chest 1991; 99: 1328-9.
8. Buccheri G, Ferrigno D. Prognostic value of stage grouping and TNM descriptors in lung cancer. Chest 2000; 117: 1247-55.
9. Buccheri G, Ferrigno D. Lung tumour markers in oncology practice: A study of TPA and CA 125. Br J Cancer 2002; 87: 1112-8.
10. Siegel S. Nonparametric statistics for the behavioural sciences. New York: MacGraw Hill, 1956.
11. Kaplan EL, Meier F. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 58: 457-81.
12. Peto R, Pike MC, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II Analysis and examples. British Journal of Cancer 1977; 35: 1-39.
13. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-220.
14. Franceschi S, Bidoli E. The epidemiology of lung cancer. Ann Oncol 1999; 10 Suppl 5:S3-S6.
15. Jemal A, Chu KC, Tarone RE. Recent Trends in Lung Cancer Mortality in the United States. Journal of the National Cancer Institute 2001; 93: 277-83.
16. Myrdal G, Lambe M, Bergstrom R, Ekbom A, Wagenius G, Stahle E. Trends in lung cancer incidence in Sweden with special reference to period and birth cohorts. Cancer Causes Control 2001; 12: 539-49.
17. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. British Medical Journal 2000; 321: 323-9.
18. Ferrigno D, Buccheri G, Ricca I. Prognostic significance of blood coagulation tests in lung cancer. Eur Respir J 2001; 17: 667-73.
19. Brundage MD, Davies D, Mackillop WJ. Prognostic Factors in Non-small Cell Lung Cancer: A Decade of Progress. Chest 2002; 122: 1037-57.
20. Lagakos SW. Prognostic factors for patients with inoperable lung cancer. In: SCraus MJ. Lung cancer: clinical diagnosis and treatment. New York: Gune & Stratton, 1983: 345-53.
21. Osterlind K, Ihde DC, Ettinger DS, Gralla RJ, Karrer K, Krauss S. et al. Staging and prognostic factors in small cell carcinoma of the lung. Cancer Treat Rep 1983; 67: 3-9.
22. Stahel RA, Ginsberg R, Havemann K, Hirsch FR, Ihde DC, Jassem J et al. Staging and prognostic factors in small cell lung cancer: A consensus report. Lung Cancer 1989; 5: 119-26.
23. Feld R, Arriagada R, Ball DL, Mattson K, Sorensen JB. Prognostic factors in non-small cell lung cancer: A consensus report. Lung Cancer 1991; 7: 3-5.
24. Maki E, Feld R. Prognostic factors in patients with non-small cell lung cancer. A critique of the world literature. Lung Cancer 1991; 7: 27-34.
25. Ferrigno D, Buccheri G, Camilla T. Prognosis and lung cancer: the contribution of plasma proteins. Oncol Rep 1995; 2: 637-41.
26. Ferrigno D, Buccheri G, Camilla T. Serum copper and zinc content in non-small cell lung cancer: Abnormalities and clinical correlates. Monaldi Arch Chest Dis 1999; 54: 204-8.
27. Kanda T, Soda H, Tanigushi T, Kinoshita A, Fukuda M, Soejima T et al. Prognostic factors in nonresected adenocarcinoma of the lung. Gan No Rinsho 1987; 33: 1259-65.
28. Pedersen LM, Milman N. Prognostic significance of thrombocytosis in patients with primary lung cancer. The European Respirator Journal 1996; 9: 1826-30.
29. Paesmans M, Sculier JP, Libert P, Bureau G, Dabouis G, Thiriaux J et al. Prognostic factors for survival in advanced non-small-cell lung cancer: Univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1, 052 patients. Journal of Clinical Oncology 1995; 13: 1221-30.
30. Stanley KE. Prognostic factors for survival in patients with inoperable lung cancer. Journal of the National Cancer Institute 1980; 65: 25-32.
31. Sorensen JB, Badsberg JH, Olsen J. Prognostic factors in inoperable adenocarcinoma of the lung: A multivariate regression analysis of 259 patients. Cancer Research 1989; 49: 5748-54.